UBT251
UBT251 Injection Phase II Clinical Study (CKD)
The United Bio-Technology (Hengqin) Co · Phase 2 · Recruiting · Enrollment 180
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| 2.0 mg group | Obesity or overweight | 2.0 mg | 24 | n/r | n/r |
| 4.0 mg group | Obesity or overweight | 4.0 mg | 24 | n/r | n/r |
| 6.0 mg group | Obesity or overweight | 6.0 mg | 24 | n/r | n/r |